Pediatrics
Showing 401-500 of 1,612 Results
-
Noelle Hanako Ebel
Clinical Associate Professor, Pediatrics - Gastroenterology
Current Research and Scholarly InterestsCurrent projects include:
-indications for combined heart-liver transplantation
-mitigating perioperative bleeding during cardiac surgery in children with Alagille syndrome
-congenital heart disease and liver transplantation
-subspecialty advocacy -
Elizabeth Egan
Associate Professor of Pediatrics (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsMalaria is a parasitic disease transmitted by mosquitos that is a leading cause of childhood mortality globally. Public health efforts to control malaria have historically been hampered by the rapid development of drug resistance. The goal of our research is to understand the molecular determinants of critical host-pathogen interactions in malaria, with a focus on the erythrocyte host cell. Our long-term goal is to develop novel approaches to prevent or treat malaria and improve child health.
-
Vanessa El Kamari
Instructor, Medicine - Infectious Diseases
BioVanessa El Kamari, MD, is a physician-scientist in the Division of Infectious Diseases and Geographic Medicine at Stanford University and a member of the David Relman Laboratory. Her research investigates how host–microbe interactions in the small intestine regulate mucosal immunity, barrier integrity, and systemic inflammation in autoimmune and inflammatory diseases.
Her current studies use non-invasive sampling of the small intestine in conditions such as celiac disease, multiple sclerosis, and environmental enteropathy. She applies an integrative, multi-omic approach—combining microbiology, immunology, molecular biology, and computational biology—to define spatial immune–microbial networks along the human gut.
Before joining Stanford, Dr. El Kamari’s research focused on inflammation and immune activation in chronic HIV infection, where she identified gut barrier dysfunction as a key driver of systemic inflammation and cardiometabolic complications. She also led intervention studies targeting immune activation and endothelial dysfunction in HIV, work that laid the foundation for her current efforts to apply similar mechanistic approaches to autoimmune and inflammatory disorders. -
Yasser El-Sayed, Professor
Charles B. and Ann L. Johnson Professor in the School of Medicine and Professor, by courtesy, of Pediatrics (Neonatology) and of Surgery
Current Research and Scholarly InterestsHigh Risk Obstetrics: preterm labor, preeclampsia, medical and surgical complications of pregnancy, prenatal diagnosis and therapy
-
Gregory Enns
Professor of Pediatrics (Genetics)
Current Research and Scholarly Interestsmitochondrial genomics, lysosomal disorders, tandem-mass spectrometry newborn screening, and inborn errors of metabolism presentations and natural history
-
Mgbechi Ugonna Erondu
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
Clinical Assistant Professor (By courtesy), PediatricsBioMgbechi Ugonna Erondu, MD MFA is currently a Clinical Assistant Professor for the Department of Anesthesia, Pain and Perioperative Medicine and the Division of Quality of Life and Pediatric Palliative Care at Stanford University and is board-certified in Pediatric Anesthesiology and Hospice and Palliative Medicine. Her academic interests include the intersection between fiction writing and medical humanities, perioperative management of pediatric palliative care patients, interdisciplinary care of persons living with sickle cell disease, and equitable and inclusive global health practices.
-
Carlos O. Esquivel, M.D., Ph.D.,FACS
Arnold and Barbara Silverman Professor in Pediatric Transplantation and Professor of Surgery (Abdominal Transplantation) and of Pediatrics (Gastroenterology, Hepatology and Nutrition)
Current Research and Scholarly Interests1) Induction of immunotolerance
2) Rejection of liver and intestinal transplantation.
3) Clinical outcomes of children with unresectable liver tumors. -
Susan Payne Etheridge
Adjunct Clinical Professor, Pediatrics - Cardiology
BioDr. Etheridge is a board-certified pediatric cardiologist and electrophysiologist. Since beginning her tenure in Pediatric Cardiology, her research focus has centered on Long QT Syndrome (LQTS) and other genetic disorders leading to sudden death in the young. She directed local and multi-center collaborative projects concerning LQTS, supraventricular tachycardia and Wolff-Parkinson-White Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia and hypertrophic cardiomyopathy. She has actively participated in multicenter projects of genetic conditions associated with sudden death in the young, including Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), Timothy Syndrome, Andersen-Tawil Syndrome, hypertrophic cardiomyopathy, sudden death in athletes, and fetal LQTS. She was the local PI for multicenter projects on hypertrophic cardiomyopathy, fetal and nonfetal LQTS, Wolff-Parkinson-White Syndrome, Timothy Syndrome and CPVT. She is an an invited speaker at local, national, and international meetings where she speaks largely on the genetic susceptibility to sudden death in the young and WPW. She has published book chapters and invited editorials and articles related to heritable sudden death conditions and sports participation and arrhythmias in congential heart disease.
Her experience as a pediatric electrophysiologist, a Fellow in the Heart Rhythm Society, past present of the Pediatric and Congenital Arrhythmia Society, member of the America College of Cardiology Electrophysiology Committee and Vice President of the Sudden Arrhythmia Death Foundation underscores her interest in and service to children and adults with arrhythmic disease. Her years on the American Board of Pediatrics and her past leadership role within the fellowship speak to her dedication to the next generation of pediatric cardiologitsts. Dr. Etheridge created and led the University of Utah Inherited Arrhythmia clinic. This is a collaborative clinic that focuses on children and adults with familial sudden death conditions with input from genetics, adult and pediatric electrophysiology and child psychology. The goal was the pre-symptomatic assessment and sudden death prevention in patients with inherited arrhythmia conditions and care for the child and the entire family. The team followed the nationally defined protocols for this assessment and engage our research, genetics and adult electrophysiology colleagues in this assessment. She is embarking upon a similar role at Stanford University. As the Vice President of the SADS Foundation, she is intimately involved with families with these conditions. She takes part in and has developed educational seminars concerning these conditions as part of her involvement with SADS. She often faces questions concerning sports participation in children and young adults with inherited conditions that put children at risk for sudden death. She is a part of the writing group for a recently published consensus document on return to play with heart conditions from the Heart Rhythm Society, American College of Cardiology and the American Heart Association.
She has dedicated some of her clinical work to the care of adults with arrhytmias in the setting of congenital heart disease and has a clinic for this population in California, Alaska and Idaho. She is scheduled to co-chair the upcoming HRS document on arrhythmia management in adults with congenital heart disease. -
Ryann Fame, PhD
Assistant Professor of Neurosurgery (Adult Neurosurgery)
Current Research and Scholarly InterestsEarly neural progenitors respond to extrinsic cues that maintain and support their potency. These stem/ progenitor cells are in direct contact with the cerebrospinal fluid (CSF), which acts as part of their niche. Our research program encompasses the early neural stem cell niche, neural tube closure, CSF, metabolism, and cortical neuronal development. We are dedicated to broad collaboration focused on translating an understanding of neurodevelopment and CSF biology into regenerative strategies.
-
Jeffrey A. Feinstein, MD, MPH
Dunlevie Family Professor of Pulmonary Vascular Disease and Professor, by courtesy, of Bioengineering
Current Research and Scholarly InterestsResearch interests include (1) computer simulation and modeling of cardiovascular physiology with specific attention paid to congenital heart disease and its treatment, (2) the evaluation and treatment of pulmonary hypertension/pulmonary vascular diseases, and (3) development and testing of medical devices/therapies for the treatment of congenital heart disease and pulmonary vascular diseases.
-
Heidi M. Feldman
Professor of Pediatrics (Developmental-Behavioral)
Current Research and Scholarly InterestsMy current research program focuses on infants born preterm, before 32 weeks gestation from two language environments: English and Spanish. The study considers how neurobiological factors, specifically properties of the white matter circuits in the brain, interact with social, psychological, and economic factors to predict language processing efficiency at 18 months of age.
-
Philip Fernandes
Masters Student in Translational Research and Applied Medicine, admitted Autumn 2026
Fellow in Pediatrics - GastroenterologyBioI am a Clinical Fellow in Pediatric Gastroenterology, Hepatology, and Nutrition and a Tashia and John Morgridge Endowed Postdoctoral Fellow at Stanford University and Lucile Packard Children’s Hospital, supported by the Maternal & Child Health Research Institute. I completed my residency at Henry Ford St. John Hospital in Detroit, where caring for diverse communities shaped my dedication to health equity and cultural humility.
In the Rosen Lab, my research centers on pediatric ulcerative colitis (UC). I use 3D colonoids—lab-grown models of the colon derived from intestinal stem cells—alongside single-cell genomic technologies to map cellular metabolic changes and cell-to-cell interactions. By decoding these cellular dynamics, my goal is to uncover targeted, precise therapies that better control disease, prevent complications, and support long-term growth, nutrition, and overall health for pediatric patients.
This work builds on my foundation in pediatric gastroenterology at the University of Virginia’s Syed Lab, where I contributed to data interpretation, grant development, and multi-institutional research integrating genomics and machine learning to investigate gastrointestinal structure and function.
As a student in the Master's in Translational Research and Applied Medicine (M-TRAM) program, I am building actionable skills across clinical medicine, translational research, and industry-driven approaches to innovation, preparing to advance therapeutics for complex pediatric enteropathies. -
Nielsen Fernandez-Becker
Clinical Professor, Medicine - Gastroenterology & Hepatology
BioI am the director of the Celiac Disease Program at Stanford and I am highly experienced in diagnosis and management of celiac disease and gluten associated disorders.
My objective is to provide excellent and compassionate clinical care for my patients while seeking a better understanding of diseases I treat, particularly Celiac disease (CeD), eosinophilic esophagitis (EoE). My top priorities are patient care and translational research to make new discoveries and improve the care my patients. -
Caroline Figueroa, MD PhD
Visiting Scholar, Pediatrics - General Pediatrics
BioCaroline Figueroa, MD, PhD, is a visiting scholar at Stanford University. She is the 2025–26 Dutch Commonwealth Fund Harkness Fellow in Health Care Policy and Practice. She is an assistant professor at Delft University of Technology (TU Delft) in the Netherlands, where she leads the Research on Inclusive Solutions and Empowerment in Digital Health (RISE) group. Her work focuses on making digital mental health solutions — such as apps and AI-chatbots — safe, effective, and accessible, particularly for adolescents, young adults, and women. Figueroa’s research on digital health equity has directly informed policy documents by global organizations such as the World Health Organization and the United Nations, and has been published in leading journals including Lancet Digital Health, Journal of the American Medical Informatics Association, and Human Brain Mapping.
Figueroa is a medical doctor with a PhD in the neuroscience of depression from the University of Amsterdam and the University of Oxford; she also has several years of experience in clinical psychiatry. Before joining TU Delft, she was a postdoctoral scholar at the University of California, Berkeley. -
Michael Fischbach
Liu (Liao) Family Professor
Current Research and Scholarly InterestsThe microbiome carries out extraordinary feats of biology: it produces hundreds of molecules, many of which impact host physiology; modulates immune function potently and specifically; self-organizes biogeographically; and exhibits profound stability in the face of perturbations. Our lab studies the mechanisms of microbiome-host interactions. Our approach is based on two technologies we recently developed: a complex (119-member) defined gut community that serves as an analytically manageable but biologically relevant system for experimentation, and new genetic systems for common species from the microbiome. Using these systems, we investigate mechanisms at the community level and the strain level.
1) Community-level mechanisms. A typical gut microbiome consists of 200-250 bacterial species that span >6 orders of magnitude in relative abundance. As a system, these bacteria carry out extraordinary feats of metabolite consumption and production, elicit a variety of specific immune cell populations, self-organize geographically and metabolically, and exhibit profound resilience against a wide range of perturbations. Yet remarkably little is known about how the community functions as a system. We are exploring this by asking two broad questions: How do groups of organisms work together to influence immune function? What are the mechanisms that govern metabolism and ecology at the 100+ strain scale? Our goal is to learn rules that will enable us to design communities that solve specific therapeutic problems.
2) Strain-level mechanisms. Even though gut and skin colonists live in communities, individual strains can have an extraordinary impact on host biology. We focus on two broad (and partially overlapping) categories:
Immune modulation: Can we redirect colonist-specific T cells against an antigen of interest by expressing it on the surface of a bacterium? How do skin colonists induce high levels of Staphylococcus-specific antibodies in mice and humans?
Abundant microbiome-derived molecules: By constructing single-strain/single-gene knockouts in a complex defined community, we will ask: What are the effects of bacterially produced molecules on host metabolism and immunology? Can the molecular output of low-abundance organisms impact host physiology?
3) Cell and gene therapy. We have begun two new efforts in mammalian cell and gene therapies. First, we are developing methods that enable cell-type specific delivery of genome editing payloads in vivo. We are especially interested in delivery vehicles that are customizable and easy to manufacture. Second, we have begun a comprehensive genome mining effort with an emphasis on understudied or entirely novel enzyme systems with utility in mammalian genome editing. -
Paul Graham Fisher, MD
Beirne Family Professor of Pediatric Neuro-Oncology, Professor of Pediatrics and, by courtesy, of Neurosurgery and of Epidemiology and Population Health
Current Research and Scholarly InterestsClinical neuro-oncology: My research explores the epidemiology, natural history, and disease patterns of brain tumors and other cancers in childhood, as well as prospective clinical trials for treating these neoplasms. Research interests also include neurologic effects of cancer and its therapies.
-
Philip Andrew Fisher
Diana Chen Professor of Early Childhood Learning and Professor, by courtesy, of Pediatrics
BioDr. Philip Fisher is the Diana Chen Professor of Early Childhood Learning in the Graduate School of Education and the Director of the Stanford Center on Early Childhood. His research, focuses on developing and evaluating scalable early childhood interventions in communities, and on translating scientific knowledge regarding healthy development under conditions of adversity for use in social policy and programs. He is particularly interested in the effects of early stressful experiences on children's development, and in prevention and treatment programs for improving children's functioning in areas such as relationships with caregivers and peers, social-emotional development, and academic achievement. He is currently the lead investigator in the ongoing RAPID-EC project, a national survey on the well-being of households with young children during the COVID-19 pandemic. Dr. Fisher is the developer of a number of widely implemented evidence-based interventions for supporting healthy child development in the context of social and economic adversity, including Treatment Foster Care Oregon for Preschoolers (TFCO-P) and Kids in Transition to School (KITS). Most recently, he developed the Filming Interactions to Nurture Development (FIND) video coaching program for supporting parenting in the home environment and early childhood care and education professionals in childcare and preschool contexts. He has published over 250 scientific papers in peer reviewed journals. He is the recipient of the 2012 Society for Prevention Research Translational Science Award, and a 2019 Fellow of the American Psychological Society.
-
Barry Fleisher
Associate Professor of Pediatrics at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsNeonatology, neurobehavioral development, outcomes in premature infants.
-
Eric Foote
Clinical Assistant Professor, Pediatrics - Neonatology
BioEric Foote is a pediatric hospitalist with experience conducting clinical and public health research around the world. His research focuses on identifying and intervening on health disparities in low income countries and in low resource settings. Currently, he is developing and evaluating a community health worker-led household phototherapy intervention to extend access to neonatal jaundice care for newborns in rural Bangladesh. He is also working to improve SARS-CoV-2 testing and genomic surveillance across California and worldwide.
-
James Ford
Professor of Medicine (Oncology) of Genetics and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsMammalian DNA repair and DNA damage inducible responses; p53 tumor suppressor gene; transcription in nucleotide excision repair and mutagenesis; genetic determinants of cancer cell sensitivity to DNA damage; genetics of inherited cancer susceptibility syndromes and human GI malignancies; clinical cancer genetics of BRCA1 and BRCA2 breast cancer and mismatch repair deficient colon cancer.
-
Uta Francke
Professor of Genetics and of Pediatrics, Emerita
Current Research and Scholarly InterestsFunctional consequences and pathogenetic mechanisms of mutations and microdeletions in human neurogenetic syndromes and mouse models. Integration of genomic information into medical care.
-
Eliana Frank
Division Clinical Research Manager, Pediatrics - Endocrinology
Current Role at StanfordDivision Clinical Research Manager - Pediatric Endocrinology
-
Jennifer Frankovich
Clinical Professor, Pediatrics - Rheumatology
Current Research and Scholarly InterestsMy primary interest and role at Stanford is to evaluate and treat children with both systemic and organ specific autoimmune disease. In October of 2012, we started a multidisciplinary clinic dedicated to treating patients with PANS (Pediatric Acute-onset Neuropsychiatric Syndromes). I am currently the clinical and research director for the PANS program.
-
Michael Freedman
Clinical Instructor, Pediatrics - Cardiology
BioPediatric critical care fellow and computational modeler with a decade of experience across bioengineering, pharma R&D, decision science, epidemiology, consulting, and startups. In pursuit of improving outcomes, minimizing cost, and maximizing equity in pediatric health, both inside and outside the PICU.
-
Matilda Fresk
LSRP 2, Pediatrics - Gastroenterology
BioBiorepository Manager and Life Science Research Professional at Stanford Medicine. Matilda supports both the Center for IBD and Celiac Disease and Dr. Michael Rosen’s Lab, where her primary focus is the administration and execution of the Biorepository study.
Her role bridges strategic operations with hands-on technical execution. She oversees the development of SOPs, inventory management, and maintains direct contact with the cohort of research participants and their families. She also collaborates closely with research labs across Stanford to supply them with biorepository samples, ensuring full regulatory compliance and proper documentation for all de-identified sample transfers. Furthermore, she provides integral support for the Clinical Research Coordinators (CRCs) on key initiatives, including the CAPTURE IBD and MUSIC-CD studies, managing essential processes such as visit registration, supply procurement, research kit preparation, and biospecimen processing.
She brings a deeply technical engineering background, with over three years specialized in the generation, characterization, and affinity purification of antibody-based constructs and AAV vectors, with a strong understanding of process development. Previously a Research Engineer at KTH Royal Institute of Technology, where she coordinated autoimmune research with the Karolinska Institute.
She holds both an MSc and a BSc in Medical Biotechnology from KTH Royal Institute of Technology. -
Adam Frymoyer
Clinical Professor, Pediatrics - Neonatology
Current Research and Scholarly InterestsMy research uses quantitative pharmacology and quality improvement science to improve care for neonates and children. I develop individualized, evidence-based dosing strategies and translate them into real-time clinical tools, while leading research to identify and close gaps between evidence and practice across the newborn continuum. Across both programs, my goal is to translate rigorous science into better bedside care and improve child health.
-
Janene Fuerch
Clinical Professor, Pediatrics - Neonatology
BioJanene H. Fuerch, MD is a Clinical Professor of Neonatology at Stanford University Medical Center, as well as an innovator, educator, researcher and physician entrepreneur. She has an undergraduate degree in Neuroscience from Brown University and a medical degree from the Jacobs School of Medicine at SUNY Buffalo. At Stanford University she completed a pediatrics residency, neonatal-perinatal medicine fellowship and the Byers Center for Biodesign Innovation Fellowship.
She is also Assistant Director of the Biodesign Innovation Fellowship Program at Stanford University, and Co-Director of Impact1 where she mentors and advises new entrepreneurs through all aspects of medical device development, from identifying clinical needs to commercialization. Her specific areas of investigational interest include the development and commercialization process of neonatal, pediatric and maternal health medical devices as well as the utilization of a simulated environment to develop and test medical devices. She is a national leader in neonatal resuscitation, ECMO, device development and has been an AHRQ and FDA funded investigator. But her work extends outside of the academic realm to industry having co-founded EMME (acquired by Simple Health 2022) an award-winning reproductive health company, medical director for Novonate (acquired by Laborie 2023) a neonatal umbilical catheter securement company and notable consultant for Vitara (EXTEND - artificial environment to decrease complications of prematurity), and Avanos™. Janene is passionate about improving the health of children and newborns through medical device innovation and research. -
Xavier Gaeta MD PhD
Instructor, Pediatrics - Nephrology
BioDr. Xavier Gaeta is an Instructor in the division of Pediatric Nephrology and a postdoctoral fellow in the lab of Dr. Calvin J. Kuo. His research interests include using three-dimensional human kidney organoids and genetic engineering techniques to model human kidney disease, kidney development, and cancer in vitro.
-
Francisco Galdos
Fellow in Pediatrics - Cardiology
BioFrancisco earned his undergraduate degree in Human Developmental and Regenerative Biology from Harvard University, graduating magna cum laude. He subsequently completed his MD/PhD at Stanford University School of Medicine. During his doctoral training under the mentorship of Dr. Sean Wu, Francisco published one of the first comprehensive maps of human cardiac cell development using pluripotent stem cell-based models. His research contributed to the development of machine learning tools and genetic tracing systems that identified and characterized human left ventricular cardiomyocytes in vitro, enabling the modeling of left ventricular development in hypoplastic left heart syndrome. Francisco has authored multiple first-author publications and has been awarded funding from both internal sources and the NIH (F30, T32). He has received numerous accolades for his work, including the prestigious Harold Weintraub Award, and has presented his research at various national conferences. As part of the accelerated research pathway at Stanford, Francisco is focused on the genetic and epigenetic mechanisms underlying heart failure and heart development in congenital heart disease, with the ultimate goal of developing novel therapeutics for pediatric patients.
-
Rodrigo B. Galindo
CAPE Simulation Lab Manager and Operations Specialist, Pediatrics - Neonatology
Current Role at StanfordRodrigo Galindo manages technology and supports research and education for simulation programs at the Center for Advanced Pediatric & Perinatal Education (CAPE) (http://cape.stanford.edu) within the School of Medicine/Pediatrics/Neonatology division. He also assists with collaborative quality improvement initiatives between CAPE and the departments of Labor & Delivery, Neonatal Intensive Care Unit (NICU), and Obstetrics at Lucile Packard Children’s Hospital.
-
Hayley Gans
Current Research and Scholarly InterestsThe focus of my laboratory is the immune response to viral vaccines evaluating the ontogeny of responses in infants and limitations in immunocompromised hosts. We have studied responses to an early two-dose measles immunization, one versus 2 doses of varicella immunization, and polio vaccine in preterm versus term infants. Other active areas of research include measles and varicella immunity in HIV infected individuals, and transplant recipients.
-
Chris Garcia
Younger Family Professor and Professor of Structural Biology
Current Research and Scholarly InterestsStructural and functional studies of transmembrane receptor interactions with their ligands in systems relevant to human health and disease - primarily in immunity, infection, and neurobiology. We study these problems using protein engineering, structural, biochemical, and combinatorial biology approaches.
-
Manuel Garcia-Careaga
Current Research and Scholarly InterestsGastroenterology, liver disease in cystic fibrosis patients, percutaneous gastrostomy tube in pediatric population, inflamatory bowel disease, failure to thrive
-
Christopher Gardner
Rehnborg Farquhar Professor
Current Research and Scholarly InterestsThe role of nutrition in individual and societal health, with particular interests in: plant-based diets, differential response to low-carb vs. low-fat weight loss diets by insulin resistance status, chronic disease prevention, randomized controlled trials, human nutrition, community based studies, Community Based Participatory Research, sustainable food movement (animal rights and welfare, global warming, human labor practices), stealth health, nutrition policy, nutrition guidelines
-
Brice Gaudilliere
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD) and, by courtesy, of Pediatrics (Neonatology)
Current Research and Scholarly InterestsThe advent of high dimensional flow cytometry has revolutionized our ability to study and visualize the human immune system. Our group combines high parameter mass cytometry (a.k.a Cytometry by Time of Flight Mass Spectrometry, CyTOF), with advanced bio-computational methods to study how the human immune system responds and adapts to acute physiological perturbations. The laboratory currently focuses on two clinical scenarios: surgical trauma and pregnancy.
-
Charles Gawad
Associate Professor of Pediatrics (Hematology/Oncology)
BioOur lab works at the interface of biotechnology, computational biology, cellular biology, and clinical medicine to develop and apply new tools for characterizing genetic variation across single cells within a tissue with unparalleled sensitivity and accuracy. We are focused on applying these technologies to study cancer clonal evolution while patients are undergoing treatment with the aim of identifying cancer clonotypes that are associated with resistance to specific drugs so as to better understand and predict treatment response. We are also applying these methods to understand how more virulent pathogens emerge from a population of bacteria or viruses with an emphasis on developing a deeper understanding of how antibiotic resistance develops.
-
Benedikt Geier
Postdoctoral Scholar, Infectious Diseases
BioB.Sc. Biology, Ludwig Maximilian University (LMU), Munich/Germany (2013)
M.Sc. Biology and bioimaging, Ludwig Maximilian University (LMU), Munich/Germany (2015)
Ph.D., Animal-Microbe Symbioses, Max Planck Institute for Marine Microbiology in Bremen/Germany (2020)
Benedikt joined the Amieva Lab from Germany in 2022. During his B.Sc. and M.Sc. programs in zoology, he became fascinated with 3D imaging approaches to study small animal microanatomy. He spent his PhD developing in situ imaging approaches to study deep-sea symbioses and fell in love with studying host-microbe interactions. In the Amieva Lab, Benedikt will advance his previously developed correlative chemical imaging techniques to resolve metabolic and cellular interactions that drive H. pylori pathogenesis in the gastric glands.
More about Benedikt's transition from deep-sea microbiology into infectious disease research can be found here:
https://scopeblog.stanford.edu/2022/08/24/unconventional-paths-deep-sea-to-the-stomach/ -
Yael Gernez
Clinical Associate Professor, Pediatrics - Immunology
BioMy clinic focuses on solving the molecular puzzles that underlie rare allergic and immunologic diseases to shed light on fundamental principles governing allergy, inflammation and immune system defects. My goal is to find better and safer therapies for my patients with rare diseases that include autoinflammation, autoimmunity and primary immune deficiency. It is important to highlight that every patient requires individualized therapeutic approaches based on their underlying genetic problem and the types and severity of their clinical manifestations. For some patients, a hematopoietic stem cell transplant (HSCT) is curative while for others, a targeted drug therapy, such as a biologic or small molecule agent, is most suitable. In some cases, a truly novel therapy may be required, .e.g., anti-sense oligonucleotide therapy to suppress aberrant gene splicing or adoptive cellular therapy. My passion is to provide the best personalized therapy for our patients with allergy and immunology diseases. This often requires performing very specialized functional assays and in some cases in enlisting laboratories with specific expertise or interest in particular genetic disorders.
-
Zahra Ghazi-Askar
Clinical Associate Professor, Emergency Medicine
Clinical Associate Professor, PediatricsBioDr. Ghazi-Askar is Assistant Professor of Emergency Medicine and, by courtesy, of Pediatrics and serves as the Director of Pediatric Ultrasound Education in the Department of Emergency Medicine . As an academic clinical educator in with expertise in pediatric and adult point-of-care ultrasound, Dr. Ghazi-Askar's clinical focus is on children and young adults who seek care in the pediatric emergency department. She is specialty-board certified in pediatric emergency medicine.
At a national level, Dr. Ghazi-Askar is the Chair of Point-of-Care Ultrasound subcommittee for the Association of Pediatric Program Directors (APPD), where she is leading the development of an educational curriculum for pediatric residency point-of-care ultrasound.
Dr. Ghazi-Askar also has expertise in the field of Tele-ultrasound, where she is able to teach point-of-care ultrasound virtually where clinical expertise may otherwise not be available. Here she is able to provide education and health equity when it is most needed.
